Renaissance Capital logo

Flexion Therapeutics Priced, Nasdaq: FLXN

Developing sustained-release injectable pain therapies for osteoarthritis.

Industry: Health Care

First Day Return: +13.2%

Industry: Health Care

Developing sustained-release injectable pain therapies for osteoarthritis.
more less

Flexion Therapeutics (FLXN) Performance